Back
Buyer Group International, Inc. Vs. BridgeBio Pharma, Inc. Industry Stock Comparison
Sell
18
BYRG
Buyer Group International, Inc.
Last Price:
$0.0000
Seasonality Move:
-14.83%
Buy
51
BBIO
BridgeBio Pharma, Inc.
Last Price:
$73.17
Seasonality Move:
5.25%
Sell
18
Buyer Group International, Inc. (BYRG)
is a Sell
Is Buyer Group International, Inc. a Buy, Sell or Hold?
-
The current Buyer Group International, Inc. [BYRG] share price is $0.0010. The Score for BYRG is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
-
BYRG is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
51
BridgeBio Pharma, Inc. (BBIO)
is a Buy
Is BridgeBio Pharma, Inc. a Buy, Sell or Hold?
-
The current BridgeBio Pharma, Inc. [BBIO] share price is $73.15. The Score for BBIO is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
BBIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BYRG Stock Price Chart
What is Buyer Group International, Inc.'s stock price today?
-
The Buyer Group International, Inc. share price today is $0.0010Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BYRG is experiencing selling pressure, which indicates risk of future bearish movement.
BBIO Stock Price Chart
What is BridgeBio Pharma, Inc.'s stock price today?
-
The BridgeBio Pharma, Inc. share price today is $73.15Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BBIO is experiencing slight selling pressure.
BYRG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 34.33 | Sell |
| Chaikin Money Flow: | -393277 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.0013 - 0.0013) | Sell |
| Bollinger Bands (100): | (0.0021 - 0.0021) | Sell |
BBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.66 | Buy |
| Relative Strength Index (14 RSI): | 55.21 | Buy |
| Chaikin Money Flow: | -128497 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (66.58 - 72.4) | Buy |
| Bollinger Bands (100): | (67.73 - 76.59) | Buy |
BYRG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0 | Sell |
| 20-day SMA: | 0 | Sell |
| 50-day SMA: | 0 | Sell |
| 200-day SMA: | 0 | Sell |
| 8-day EMA: | 0 | Sell |
| 20-day EMA: | 0 | Buy |
| 50-day EMA: | 0 | Buy |
| 200-day EMA: | 0 | Buy |
BBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 71.71 | Buy |
| 20-day SMA: | 70.4 | Buy |
| 50-day SMA: | 71.53 | Buy |
| 200-day SMA: | 61.39 | Buy |
| 8-day EMA: | 72.08 | Buy |
| 20-day EMA: | 70.93 | Buy |
| 50-day EMA: | 70.94 | Buy |
| 200-day EMA: | 62.01 | Buy |
Buyer Group International, Inc. Earnings Growth & BYRG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
BridgeBio Pharma, Inc. Earnings Growth & BBIO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.27 per share, an increase next quarter of $0.26 per share, an increase this year of $1.05 per share, and an increase next year of $2.15 per share.
Buyer Group International, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
BridgeBio Pharma, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||